Arca
Skip to content
Tools
Tools

CD70: CD70 antigen

Expressed at the plasma membrane of B cells, it is the ligand of the CD27 receptor which is specifically expressed at the surface of T cells.

  • Drugs that act on it: 4
  • Approved: 0
  • In phases 1 to 3: 4
  • Sponsors: 3

Who is on it, and how far along

Every drug ChEMBL records acting on CD70, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Antibody 2
  • Antibody-drug conjugate 1
  • Other 1

Approved0

    Phase 30

      Phase 23

      • Cusatuzumab
      • Vorsetuzumab
      • Vorsetuzumab mafodotin

      Phase 11

      • MDX-1411

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      CusatuzumabPhase 2OncoVerityAntibodyInhibitorCD70 antigen inhibitor3
      VorsetuzumabPhase 2—AntibodyBinding agentCD70 antigen binding agent0
      Vorsetuzumab mafodotinPhase 2PfizerAntibody-drug conjugateBinding agentCD70 antigen binding agent0
      MDX-1411Phase 1Bristol-Myers SquibbOtherCross-linking agentCD70 antigen cross-linking agent0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 3 in all, from ClinicalTrials.gov.

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      • Severe combined immunodeficiency due to CD70 deficiency0.66
      • Combined immunodeficiency0.46
      • Hematopoietic and lymphoid cell neoplasm0.29
      • Neurodegenerative disease0.24
      • Hereditary disease0.19
      • Neoplasm0.15
      • Non-small cell lung carcinoma0.11

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3712913, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P32970, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.